By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


PharmAthene, Inc. 

One Park Place
Suite 450
Annapolis  Maryland  21401  U.S.A.
Phone: 410-269-2600 Fax: 410-269-2601



Start Up

Company News
PharmAthene, Inc. (PIP) Receives $20 Million Payment From SIGA (SIGA) To Extend Payment Deadline 7/11/2016 6:27:26 AM
PharmAthene, Inc. (PIP) To Join Russell 3000 And Global Indexes 6/24/2016 6:33:47 AM
PharmAthene, Inc. (PIP) Reports First Quarter 2016 Financial And Operational Results 5/10/2016 8:02:11 AM
PharmAthene, Inc. (PIP) Reports Court Approval Of SIGA Reorganization Plan To Exit From Bankruptcy 4/13/2016 10:42:15 AM
Delaware Supreme Court Affirms Chancery Court Ruling In Favor Of PharmAthene, Inc. (PIP) 12/28/2015 11:40:01 AM
PharmAthene, Inc. (PIP) Adopts Stockholder Rights Plan In An Effort To Protect Net Operating Loss Carryforwards 11/30/2015 7:26:23 AM
PharmAthene, Inc. (PIP) Reports Third Quarter 2015 Financial And Operational Results 11/9/2015 10:11:35 AM
PharmAthene, Inc. (PIP) Announces Conclusion Of Oral Arguments In Its Litigation Against SIGA 10/8/2015 7:01:54 AM
PharmAthene, Inc. (PIP) Reports Second Quarter 2015 Financial And Operational Results 8/6/2015 8:35:27 AM
Immunovaccine Inc. And PharmAthene, Inc. (PIP) Sign Exclusive Worldwide License Agreement To Develop And Commercialize An Anthrax Vaccine Formulated In DepoVax 7/8/2015 10:52:03 AM